Cost–utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle‐income economy setting

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Svetlana Obrenovic, Marko M. Folic, Nevena D. Folic, Slobodan M. Jankovic
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!